Simeon George

Simeon J.
George was the founder of Nkarta, Inc., founded in 2015, where the title held was Independent Director from 2015 to 2017.
Dr. George is the founder of SR One Capital Management LP, founded in 2020, holding the title of Chief Executive Officer.
Current jobs included Chief Executive Officer at GSK Equity Investments Ltd. since 2007; Director at Bird Rock Bio Sub, Inc. since 2009; Director at Auxogyn, Inc.; Director at eFFECTOR Therapeutics Operations, Inc. since 2013; Independent Director at CRISPR Therapeutics AG since 2015; Director at Battersea Biotech, LLC; Lead Independent Director at Design Therapeutics, Inc. since 2023; Director at Simcha Therapeutics, Inc.; Director at Rezo Therapeutics, Inc.; Independent Director at Nkarta, Inc. since 2020; Independent Director at Avenzo Therapeutics, Inc.; Director at ADARx Pharmaceuticals, Inc. since 2021.
Former jobs include Independent Director at HTG Molecular Diagnostics, Inc. from 2011 to 2015; Independent Director at Genocea Biosciences, Inc. from 2013 to 2014; Director at Semprus BioSciences Corp.
from 2010 to 2012; Independent Director at Principia Biopharma, Inc. from 2011 to 2020; Independent Non-Executive Director at Turning Point Therapeutics, Inc. from 2017 to 2022; Director at Progyny, Inc. from 2012 to 2019; Director at Simcha Therapeutics Holding Co. LLC; Principal at Merrill Lynch & Co., Inc.; Associate at Goldman Sachs & Co. LLC.
Education includes undergraduate degree from The Johns Hopkins University; MBAistration from The Wharton School of the University of Pennsylvania; doctorate from the University of Pennsylvania Medical Center conferred in 2006.